Hello,
I would like to design drug targeting AKT isoforms(AKT-1/2/3) for prostate cancer. How can I test its effectiveness using C. elegans? Which strain should I consider for this study?
Thanks for your help
Hi, for designing this study you might want to consider working with akt-1 and akt-2 mutants.
Best,
Lauren